EUVIMEDEUVIMED entdecken
Kohortenstudie

Elevated carbonylated proteins are associated with major cardiovascular events in patients with chronic coronary syndrome: A cohort study

Krystian Mróz, Elżbieta Paszek, Mateusz Baran, Michał Ząbczyk, Saulius Butenas, Anetta Undas

Polish Heart Journal · 2024

DOI: 10.33963/v.phj.100609 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Polish Heart Journal, 2024. Verfasst von Krystian Mróz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Department of Interventional Cardiology, St. John Paul II Hospital, Kraków, Poland. Hauptthemen laut MEDLINE: Protein Carbonylation, Coronary Artery Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Protein carbonylation is reported in atherosclerosis, but its predictive value is unknown. AIMS: We evaluated plasma carbonylated protein (PC) levels in association with clinical outcomes in coronary artery disease (CAD) in long-term follow-up. METHODS: In patients with advanced stable CAD, we assessed plasma PC content along with fibrin clot properties, i.e., permeability (Ks) and clot lysis time, and its determinants: plasminogen activator inhibitor-1 (PAI-1) and thrombin-activatable fibrinolysis inhibitor. We recorded a composite of myocardial infarction, ischemic stroke, systemic embolism, and cardiovascular death during a follow-up of 8.3 (1.8) years. RESULTS: The analysis involved 178 patients aged 64.0 (57.0-70.0) years. The baseline PC content was 2.9 (2.2-3.7) nmol/mg protein and was elevated above the reference value obtained for a control group (2.03 nmol/mg protein) in 82.6% of patients. In linear regression models, high PC adjusted for age was associated with lower Ks, longer clot lysis time, and elevated PAI-1 and thrombin-activatable fibrinolysis inhibitor. Baseline PC was 48% higher in patients with the composite endpoint (n = 67, 37.6%) compared with others (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein CarbonylationCoronary Artery DiseaseHumansFemaleMiddle AgedMaleAgedCohort StudiesPlasminogen Activator Inhibitor 1Biomarkers

Stichwörter der Autor:innen

carbonylated proteinscardiovascular deathcoronary artery diseaseischemic strokemyocardial infarctionoxidative stress

Substanzen

Plasminogen Activator Inhibitor 1Biomarkers

Autor:innen und Institutionen

  • Clinical Department of Interventional Cardiology, St. John Paul II Hospital, Kraków, Poland.
  • Clinical Department of Interventional Cardiology, St. John Paul II Hospital, Kraków, Poland. elzbieta.m.paszek@gmail.com.
  • Department of Thromboembolic Disorders, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland. elzbieta.m.paszek@gmail.com.
  • AGH University of Krakow, Kraków, Poland.
  • Department of Thromboembolic Disorders, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.
  • Krakow Center for Medical Research and Technologies, St. John Paul II Hospital, Kraków, Poland.

Zitieren

APA

Mróz, K., Paszek, E., Baran, M., Ząbczyk, M., Butenas, S., & Undas, A. (2024). Elevated carbonylated proteins are associated with major cardiovascular events in patients with chronic coronary syndrome: A cohort study. Polish Heart Journal. https://doi.org/10.33963/v.phj.100609

Vancouver

Mróz K, Paszek E, Baran M, Ząbczyk M, Butenas S, Undas A. Elevated carbonylated proteins are associated with major cardiovascular events in patients with chronic coronary syndrome: A cohort study. Polish Heart Journal. 2024. doi:10.33963/v.phj.100609

BibTeX
@article{Mrz2024,
  author = {Mróz, Krystian and Paszek, Elżbieta and Baran, Mateusz and Ząbczyk, Michał and Butenas, Saulius and Undas, Anetta},
  title = {Elevated carbonylated proteins are associated with major cardiovascular events in patients with chronic coronary syndrome: A cohort study},
  journal = {Polish Heart Journal},
  year = {2024},
  doi = {10.33963/v.phj.100609}
}
Kostenlos starten →